Antabuse: Clinically Proven Alcohol Deterrent Therapy
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.51 | $46.16 (0%) | 🛒 Add to cart |
| 120 | $0.48 | $61.55 $57.20 (7%) | 🛒 Add to cart |
| 180 | $0.46 | $92.32 $82.29 (11%) | 🛒 Add to cart |
| 270 | $0.44 | $138.48 $118.41 (14%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $184.64 $153.53 (17%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.95 | $57.20 (0%) | 🛒 Add to cart |
| 90 | $0.85 | $85.80 $76.26 (11%) | 🛒 Add to cart |
| 120 | $0.79 | $114.40 $94.33 (18%) | 🛒 Add to cart |
| 180 | $0.72 | $171.59 $130.45 (24%) | 🛒 Add to cart |
| 270 | $0.69 | $257.39 $185.64 (28%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $343.19 $242.84 (29%) | 🛒 Add to cart |
Synonyms | |||
Antabuse (disulfiram) is a prescription medication designed to support the treatment of chronic alcoholism by creating a physiological deterrent to alcohol consumption. It functions as an aversive therapy, inducing unpleasant effects when alcohol is ingested, thereby reinforcing abstinence. Administered under medical supervision, it is a cornerstone in comprehensive addiction management programs, particularly for motivated patients committed to long-term sobriety. Its efficacy is well-documented in clinical settings when used as part of a multifaceted treatment approach.
Features
- Active ingredient: Disulfiram 250mg or 500mg tablets
- Mechanism of action: Inhibits aldehyde dehydrogenase (ALDH), leading to acetaldehyde accumulation upon alcohol intake
- Administration: Oral tablet, once daily
- Prescription status: Schedule IV controlled substance
- Available formulations: Scored tablets for dose flexibility
- Bioavailability: Rapidly absorbed, with peak plasma concentrations within hours
- Half-life: Approximately 60–120 hours, allowing for sustained effect
Benefits
- Provides a powerful psychological and physical deterrent against alcohol consumption
- Supports long-term abstinence by creating a conditioned aversion response
- Integrates seamlessly with behavioral therapy and counseling programs
- Reduces relapse rates in committed patients when used as directed
- Offers a non-narcotic, non-addictive pharmacological option for alcohol dependence
- Empowers patients by adding a tangible barrier to impulsive drinking
Common use
Antabuse is indicated as an adjunctive therapy in the management of chronic alcohol dependence in patients who wish to maintain a state of enforced sobriety. It is most effective when incorporated into a comprehensive treatment plan that includes psychological support, counseling, and social reinforcement. Typical candidates are those who have undergone detoxification, demonstrate a clear commitment to abstinence, and understand the consequences of alcohol consumption while on the drug. It is not intended for use as a standalone treatment or for patients without full informed consent regarding its effects.
Dosage and direction
The initial dosage is typically 500mg daily for the first one to two weeks, administered orally as a single dose. Maintenance doses range from 125mg to 500mg daily, tailored to individual tolerance and therapeutic response. Tablets should be taken in the morning, with or without food, though consistency is advised. Treatment should only begin after the patient has abstained from alcohol for at least 12 hours. Dosage adjustments must be made under strict medical supervision. Duration of therapy is individualized and may extend for months or years based on clinical progress.
Precautions
Patients must be fully informed of the disulfiram-ethanol reaction (DER) and its potential severity. Regular liver function tests are mandatory due to the risk of hepatotoxicity. Use with caution in patients with diabetes, hypothyroidism, epilepsy, or renal impairment. Avoid exposure to alcohol-containing products such as cough syrups, mouthwashes, and topical preparations. Caution is advised when operating machinery until response to therapy is known. Psychiatric monitoring is recommended, as disulfiram may exacerbate underlying mental health conditions.
Contraindications
Antabuse is contraindicated in patients with severe cardiac disease, psychosis, or hypersensitivity to disulfiram or other thiuram derivatives. It must not be administered to individuals who have recently consumed alcohol or metronidazole. Contraindicated in patients with severe hepatic impairment or cirrhosis. Not recommended during pregnancy or lactation unless potential benefits outweigh risks. Avoid use in patients unable to provide informed consent or comply with alcohol avoidance.
Possible side effect
Common side effects include drowsiness, fatigue, metallic or garlic-like aftertaste, acneiform eruptions, and headache. Less frequently, patients may experience hepatotoxicity, peripheral neuropathy, optic neuritis, or psychiatric effects such as depression or psychosis. The disulfiram-ethanol reaction (DER)—characterized by flushing, tachycardia, hypotension, nausea, and vomiting—occurs only upon alcohol ingestion. Allergic dermatitis and impotence have been reported in rare cases.
Drug interaction
Concomitant use with alcohol or alcohol-containing preparations will provoke a severe reaction. Disulfiram may potentiate the effects of warfarin, phenytoin, benzodiazepines, and tricyclic antidepressants. Avoid concurrent use with metronidazole or paraldehyde. Isoniazid and ritonavir may increase the risk of neurotoxicity. Use caution with theophylline and caffeine, as disulfiram may alter their metabolism.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next dose. Do not double the dose. Consistency is critical to maintain the aversive barrier. Patients should inform their healthcare provider of any missed doses, particularly if alcohol consumption is contemplated.
Overdose
Symptoms of overdose may include nausea, vomiting, dizziness, lethargy, and neurological disturbances such as seizures or extrapyramidal symptoms. In severe cases, cardiovascular collapse or acute hepatic necrosis may occur. Management is supportive; there is no specific antidote. Gastric lavage may be considered if ingestion is recent. Activated charcoal is not effective due to rapid absorption. Hospitalization and symptomatic treatment are essential.
Storage
Store at room temperature (15–30°C) in a tightly closed container, protected from light and moisture. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Dispose of unused medication properly via a drug take-back program.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or altering any medication regimen. Individual responses to Antabuse may vary, and adherence to prescribed guidelines is essential for safety and efficacy.
Reviews
Clinical studies and patient reports consistently affirm Antabuse’s role in supporting abstinence among motivated individuals. In a 12-month randomized trial, patients using disulfiram showed a 50% higher abstinence rate compared to placebo when combined with counseling. Many users describe it as a “safety net” that reinforces willpower. However, success is highly dependent on patient commitment and comprehensive psychosocial support. Some reports note side effects such as drowsiness or taste disturbances, though these often diminish with continued use. Overall, it remains a valued tool in structured addiction recovery programs.